Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001415889-24-007439

Options or other derivatives

  • CHIEF OPERATING OFFICER acquired 351,968 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Williams Paul Christopher CHIEF OPERATING OFFICER 2024-03-06 Grant or award · Employee Stock Option (right to buy) +210,526 210,526 D
Williams Paul Christopher CHIEF OPERATING OFFICER 2024-03-06 Grant or award · Restricted Stock Units +141,442 141,442 D
Loading xslF345X05/form4-03082024_110311.xml…